193 related articles for article (PubMed ID: 8750809)
21. [Activation of complement and serial changes of anaphylatoxin (C3a, C5a) in patients for open-heart surgery using a membrane oxygenator].
Mitsuhata H; Enzan K; Hasegawa J; Matumoto S; Matsumoto J; Kurosawa S
Masui; 1992 Feb; 41(2):194-9. PubMed ID: 1552659
[TBL] [Abstract][Full Text] [Related]
22. Human C3a and C3a desArg anaphylatoxins have conserved structures, in contrast to C5a and C5a desArg.
Bajic G; Yatime L; Klos A; Andersen GR
Protein Sci; 2013 Feb; 22(2):204-12. PubMed ID: 23184394
[TBL] [Abstract][Full Text] [Related]
23. The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a.
Reed SL; Ember JA; Herdman DS; DiScipio RG; Hugli TE; Gigli I
J Immunol; 1995 Jul; 155(1):266-74. PubMed ID: 7602103
[TBL] [Abstract][Full Text] [Related]
24. Cardiac anaphylaxis. Complement activation as an amplification system.
del Balzo U; Polley MJ; Levi R
Circ Res; 1989 Sep; 65(3):847-57. PubMed ID: 2475275
[TBL] [Abstract][Full Text] [Related]
25. Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a.
Gutzmer R; Köther B; Zwirner J; Dijkstra D; Purwar R; Wittmann M; Werfel T
J Invest Dermatol; 2006 Nov; 126(11):2422-9. PubMed ID: 16778800
[TBL] [Abstract][Full Text] [Related]
26. C3a and C5a facilitates the metastasis of myeloma cells by activating Nrf2.
Xiong J; Kuang X; Lu T; Yu K; Liu X; Zhang Z; Wang W; Zhao L; Fang Q; Wu D; Wang J
Cancer Gene Ther; 2021 Apr; 28(3-4):265-278. PubMed ID: 32873871
[TBL] [Abstract][Full Text] [Related]
27. Anaphylatoxins in dilated cardiomyopathy.
Samsonov M; Nassonov E; Masenko V; Naumov V; Mareev V; Belenkov Y
J Intern Med; 1993 Aug; 234(2):139-42. PubMed ID: 8340735
[TBL] [Abstract][Full Text] [Related]
28. F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins.
Basta M; Van Goor F; Luccioli S; Billings EM; Vortmeyer AO; Baranyi L; Szebeni J; Alving CR; Carroll MC; Berkower I; Stojilkovic SS; Metcalfe DD
Nat Med; 2003 Apr; 9(4):431-8. PubMed ID: 12612546
[TBL] [Abstract][Full Text] [Related]
29. Complement activation during liver transplantation.
Tomasdottir H; Henriksson BA; Bengtson JP; Bengtsson A; Stenqvist O; Persson H
Transplantation; 1993 Apr; 55(4):799-802. PubMed ID: 8475554
[TBL] [Abstract][Full Text] [Related]
30. Alterations in plasma complement levels after human ischemic stroke.
Mocco J; Wilson DA; Komotar RJ; Sughrue ME; Coates K; Sacco RL; Elkind MS; Connolly ES
Neurosurgery; 2006 Jul; 59(1):28-33; discussion 28-33. PubMed ID: 16823297
[TBL] [Abstract][Full Text] [Related]
31. Complement c3a and c5a induce different signal transduction cascades in endothelial cells.
Schraufstatter IU; Trieu K; Sikora L; Sriramarao P; DiScipio R
J Immunol; 2002 Aug; 169(4):2102-10. PubMed ID: 12165538
[TBL] [Abstract][Full Text] [Related]
32. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
[TBL] [Abstract][Full Text] [Related]
33. Anaphylatoxin generation in acute pancreatitis.
Roxvall L; Bengtson A; Heideman M
J Surg Res; 1989 Aug; 47(2):138-43. PubMed ID: 2787873
[TBL] [Abstract][Full Text] [Related]
34. Release of anaphylatoxins during orthotopic liver transplantation.
Henriksson BA; Stenqvist O; Bengtsson JP; Bengtsson A
Transplant Proc; 1991 Jun; 23(3):1949-50. PubMed ID: 2063439
[No Abstract] [Full Text] [Related]
35. The ischaemic leg as a source of complement activation.
Bengtson A; Holmberg P; Heideman M
Br J Surg; 1987 Aug; 74(8):697-700. PubMed ID: 3498527
[TBL] [Abstract][Full Text] [Related]
36. Distinct roles of the anaphylatoxins C3a and C5a in dendritic cell-mediated allergic asthma.
Engelke C; Wiese AV; Schmudde I; Ender F; Ströver HA; Vollbrandt T; König P; Laumonnier Y; Köhl J
J Immunol; 2014 Dec; 193(11):5387-401. PubMed ID: 25355927
[TBL] [Abstract][Full Text] [Related]
37. Anaphylatoxins and terminal complement complexes in pancreatitis. Evidence of complement activation in plasma and ascites fluid of patients with acute pancreatitis.
Roxvall LI; Bengtson LA; Heideman JM
Arch Surg; 1990 Jul; 125(7):918-21. PubMed ID: 2369318
[TBL] [Abstract][Full Text] [Related]
38. Unexplained intrauterine fetal death is accompanied by activation of complement.
Richani K; Romero R; Soto E; Espinoza J; Nien JK; Chaiworapongsa T; Refuerzo J; Blackwell S; Edwin SS; Santolaya-Forgas J; Mazor M
J Perinat Med; 2005; 33(4):296-305. PubMed ID: 16207114
[TBL] [Abstract][Full Text] [Related]
39. Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease.
Belmont HM; Hopkins P; Edelson HS; Kaplan HB; Ludewig R; Weissmann G; Abramson S
Arthritis Rheum; 1986 Sep; 29(9):1085-9. PubMed ID: 3489467
[TBL] [Abstract][Full Text] [Related]
40. Removal of activated complement from shed blood: comparison of high- and low-dilutional haemofiltration.
Arnestad JP; Hyllner M; Bengtson JP; Tylman M; Mollnes TE; Bengtsson A
Acta Anaesthesiol Scand; 1998 Aug; 42(7):811-5. PubMed ID: 9698958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
